We analyzed the mRNA expression of the stem cell marker, CD44, and the stem cell‐related molecule, VEGF, in the tumor tissues from two different sites, the tumor core and tumor periphery of 22 GBM patients (Figure 1A). Here, CD44 is linked to glioblastoma.